INFINITY PHARMACEUTICALS INC's ticker is and the CUSIP is 45665G903. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $972,000 | -26.3% | 4,321 | +12.1% | 0.14% | -20.8% |
Q3 2021 | $1,318,000 | +82.3% | 3,853 | +59.3% | 0.18% | +74.5% |
Q2 2021 | $723,000 | +230.1% | 2,418 | +256.1% | 0.10% | +137.2% |
Q1 2021 | $219,000 | +742.3% | 679 | +306.6% | 0.04% | +4200.0% |
Q3 2016 | $26,000 | +18.2% | 167 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $22,000 | -98.6% | 167 | -91.5% | 0.00% | -98.8% |
Q4 2015 | $1,547,000 | -7.1% | 1,971 | 0.0% | 0.08% | +23.2% |
Q3 2015 | $1,665,000 | -22.8% | 1,971 | 0.0% | 0.07% | -12.7% |
Q2 2015 | $2,158,000 | -41.7% | 1,971 | -25.6% | 0.08% | -48.7% |
Q1 2015 | $3,703,000 | +17.6% | 2,649 | +42.0% | 0.15% | +54.0% |
Q4 2014 | $3,150,000 | +137.6% | 1,865 | +88.8% | 0.10% | +96.1% |
Q3 2014 | $1,326,000 | +88.9% | 988 | +94.5% | 0.05% | +13.3% |
Q4 2013 | $702,000 | -20.8% | 508 | 0.0% | 0.04% | -22.4% |
Q3 2013 | $886,000 | -18.1% | 508 | -23.7% | 0.06% | -19.4% |
Q2 2013 | $1,082,000 | – | 666 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 186,900 | $3,037,000 | 0.08% |
SABBY MANAGEMENT, LLC | 666 | $1,082,000 | 0.07% |
Citadel Advisors | 12,900 | $210,000 | 0.00% |